Cargando…
Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665292/ http://dx.doi.org/10.1182/blood-2022-171006 |
| _version_ | 1784831259921350656 |
|---|---|
| author | Vegivinti, Charan Thej Reddy Musunuru, Tejo Niharika Thakur, Rahul Kumar Kakumani, Venkata Kiranmayi Mehta, Ansh Krishnachandra Atalla, Eleftheria Jitta, Sahas Reddy Mehta, Mansi Keesari, Praneeth Reddy Gurunathan, Obuli srinivasan Gopi reddy, Murali Mohan Reddy |
| author_facet | Vegivinti, Charan Thej Reddy Musunuru, Tejo Niharika Thakur, Rahul Kumar Kakumani, Venkata Kiranmayi Mehta, Ansh Krishnachandra Atalla, Eleftheria Jitta, Sahas Reddy Mehta, Mansi Keesari, Praneeth Reddy Gurunathan, Obuli srinivasan Gopi reddy, Murali Mohan Reddy |
| author_sort | Vegivinti, Charan Thej Reddy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665292 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652922022-11-16 Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection Vegivinti, Charan Thej Reddy Musunuru, Tejo Niharika Thakur, Rahul Kumar Kakumani, Venkata Kiranmayi Mehta, Ansh Krishnachandra Atalla, Eleftheria Jitta, Sahas Reddy Mehta, Mansi Keesari, Praneeth Reddy Gurunathan, Obuli srinivasan Gopi reddy, Murali Mohan Reddy Blood Online Publication Only The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665292/ http://dx.doi.org/10.1182/blood-2022-171006 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Online Publication Only Vegivinti, Charan Thej Reddy Musunuru, Tejo Niharika Thakur, Rahul Kumar Kakumani, Venkata Kiranmayi Mehta, Ansh Krishnachandra Atalla, Eleftheria Jitta, Sahas Reddy Mehta, Mansi Keesari, Praneeth Reddy Gurunathan, Obuli srinivasan Gopi reddy, Murali Mohan Reddy Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection |
| title | Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection |
| title_full | Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection |
| title_fullStr | Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection |
| title_full_unstemmed | Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection |
| title_short | Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection |
| title_sort | meta-analysis on impact of rituximab in patients with hematological malignancies with covid-19 infection |
| topic | Online Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665292/ http://dx.doi.org/10.1182/blood-2022-171006 |
| work_keys_str_mv | AT vegivinticharanthejreddy metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT musunurutejoniharika metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT thakurrahulkumar metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT kakumanivenkatakiranmayi metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT mehtaanshkrishnachandra metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT atallaeleftheria metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT jittasahasreddy metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT mehtamansi metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT keesaripraneethreddy metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT gurunathanobulisrinivasan metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection AT gopireddymuralimohanreddy metaanalysisonimpactofrituximabinpatientswithhematologicalmalignancieswithcovid19infection |